perampanel 3/4 hydrate
98%
- Product Code: 50643
CAS:
1571982-04-1
| Molecular Weight: | 1450.52 g./mol | Molecular Formula: | ₄C₂₃H₁₅N₃O₃H₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Perampanel 3/4 hydrate is primarily used as an antiepileptic drug, specifically for the treatment of partial-onset seizures and generalized tonic-clonic seizures in patients with epilepsy. It functions as a non-competitive AMPA receptor antagonist, reducing excessive electrical activity in the brain that leads to seizures. This medication is often prescribed when other treatments have not been effective or are not suitable. It is available in oral tablet form and is typically taken once daily, usually in the evening, to maximize its efficacy and minimize potential side effects such as dizziness or drowsiness. Perampanel 3/4 hydrate is also being explored for its potential use in other neurological conditions, though its primary application remains in epilepsy management.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to light yellow powder |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿6,588.00 |
+
-
|
| 1.000 | 10-20 days | ฿24,165.00 |
+
-
|
| 5.000 | 10-20 days | ฿74,385.00 |
+
-
|
perampanel 3/4 hydrate
Perampanel 3/4 hydrate is primarily used as an antiepileptic drug, specifically for the treatment of partial-onset seizures and generalized tonic-clonic seizures in patients with epilepsy. It functions as a non-competitive AMPA receptor antagonist, reducing excessive electrical activity in the brain that leads to seizures. This medication is often prescribed when other treatments have not been effective or are not suitable. It is available in oral tablet form and is typically taken once daily, usually in the evening, to maximize its efficacy and minimize potential side effects such as dizziness or drowsiness. Perampanel 3/4 hydrate is also being explored for its potential use in other neurological conditions, though its primary application remains in epilepsy management.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :